Compounds > valsartan
Page last updated: 2024-08-24

valsartan and Malignant Melanoma

valsartan has been researched along with Malignant Melanoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Botton, J; Haddy, N; Mansouri, I; Semenzato, L; Zureik, M1
Tchernev, G1

Other Studies

2 other study(ies) available for valsartan and Malignant Melanoma

ArticleYear
    Journal of the American Heart Association, 2022, 12-20, Volume: 11, Issue:24

    Topics: Adult; Aged; Aged, 80 and over; Dimethylnitrosamine; Drug Contamination; Humans; Liver Neoplasms; Melanoma; Middle Aged; Valsartan

2022
NITROSOGENESIS OF CUTANEOUS MELANOMA: SIMULTANEOUSLY DEVELOPMENT OF PRIMARY CUTANEOUS THICK MELANOMA OF THE BREAST, THIN MELANOMA/DYSPLASTIC MOLE OF THE BACK DURING PARALLEL INTAKE OF BISOPROLOL, AMLODIPINE AND VALSARTAN/ HCT: NITROSAMINE POLYCONTAMINATIO
    Georgian medical news, 2023, Issue:339

    Topics: Amlodipine; Bisoprolol; Humans; Melanoma; Melanoma, Cutaneous Malignant; Mutagens; Skin Neoplasms; Valsartan

2023